DPP4 and inflammatory bowel disease: Elevated concentrations of dipeptidyl peptidase-4/CD26 have been observed in the serum of individuals with type 1 diabetes, rheumatoid arthritis, systemic lupus erythematosus, and inflammatory bowel diseases, which suggests its involvement in the pathogenesis of autoimmune disorders [87].